α-Galactosidase-A Loaded-Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration

Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease

(2015) Tali Kizhner et al.   MOLECULAR GENETICS AND METABOLISM

Understanding enzymatic acceleration at nanoparticle interfaces: Approaches and challenges

(2014) Brandy J. Johnson et al.   Nano Today

Polymer-Coated Nanoparticles Interacting with Proteins and Cells: Focusing on the Sign of the Net Charge

(2013) Dominik Hühn et al.   ACS Nano

Physicochemical Properties of Protein-Coated Gold Nanoparticles in Biological Fluids and Cells before and after Proteolytic Digestion

(2013) Munish Chanana et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Multifunctional Nanovesicle-Bioactive Conjugates Prepared by a One-Step Scalable Method Using CO2-Expanded Solvents

(2013) Ingrid Cabrera et al.   NANO LETTERS

Tracking protein corona over time

(2013) Martin Lundqvist   Nature Nanotechnology

Enzymatic characterization of highly stable human alpha-galactosidase A displayed on magnetic particles

(2012) José L. Corchero et al.   BIOCHEMICAL ENGINEERING JOURNAL

Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature

(2012) Antonio Pisani et al.   MOLECULAR GENETICS AND METABOLISM

pH-Responsive Polysaccharide-Based Polyelectrolyte Complexes As Nanocarriers for Lysosomal Delivery of Therapeutic Proteins

(2011) Marina I. Giannotti et al.   BIOMACROMOLECULES

Integrated approach to produce a recombinant, his-tagged human α-galactosidase a in mammalian cells

(2011) José Luis Corchero et al.   BIOTECHNOLOGY PROGRESS

Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide

(2011) S. Hatakeyama et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting of drugs and nanoparticles to tumors

(2010) Erkki Ruoslahti et al.   JOURNAL OF CELL BIOLOGY

Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease

(2010) Janet Hsu et al.   JOURNAL OF CONTROLLED RELEASE

New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases

(2010) Jeffrey H. Grubb et al.   REJUVENATION RESEARCH

Liposomes as ‘smart’ pharmaceutical nanocarriers

(2010) Rupa R. Sawant et al.   Soft Matter

Enzyme Replacement Therapy for Fabry Disease

(2009) Roland M. Schaefer et al.   DRUGS

Syndecan-1 regulates αvβ3and αvβ5integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor

(2009) DeannaLee M. Beauvais et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts

(2009) Caterina Porto et al.   MOLECULAR THERAPY

Intracellular Processing of Proteins Mediated by Biodegradable Polyelectrolyte Capsules

(2009) Pilar Rivera-Gil et al.   NANO LETTERS

Understanding biophysicochemical interactions at the nano–bio interface

(2009) Andre E. Nel et al.   NATURE MATERIALS

Preparation of Uniform Rich Cholesterol Unilamellar Nanovesicles Using CO2-Expanded Solvents

(2008) Mary Cano-Sarabia et al.   LANGMUIR

Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells

(2008) Jin-Song Shen et al.   MOLECULAR GENETICS AND METABOLISM

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

(2008) M. Lundqvist et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA